# DAPTOMYCIN
> **NDA210282** · New Drug Application · Sponsor: HOSPIRA · Approved 2021-06-21
## Drug
- **FDA Application Number:** NDA210282
- **Application type:** New Drug Application
- **Brand name:** DAPTOMYCIN
- **Generic name:** DAPTOMYCIN
- **Active ingredients:** DAPTOMYCIN
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** HOSPIRA
- **Manufacturer:** Hospira, Inc.
- **First approval:** 2021-06-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210282)
---
*AI Analytics · CC0 1.0*